Impact on Quality of Life 3 Years After Diagnosis of Prostate Cancer

To study the quality of life of patients with prostate cancer at a distance from their care at a time when they are supposed to have taken a "normal" life and compared to subjects without cancer prostate of the same age.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Prostatic Neoplasms Genital Diseases Genital Diseases, Male Genital Neoplasms, Male Male Urogenital Diseases Neoplasms Neoplasms by Site Prostatic Diseases Quality of Life Urogenital Diseases Urogenital Neoplasms

Age range

Up to 75 year

Sex eligibility

Male

Study type

Observational

Primary location

CHU de Nîmes

Nîmes, Gard, 30029, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

exposed group

Inclusion criteria

prostate cancer diagnosed from 1 December 2011 to 31 December 2014
under 75 and residing in the Hérault department at diagnosis
recruited in the EPICAP study

Exclusion criteria

having relapsed in the range
non-exposed group:

Inclusion criteria

controls (without prostate cancer) recruited in the EPICAP study
matched to cases on age (5 years)
residing in the Hérault department

Exclusion criteria

diagnosis of prostate cancer set in the range

Treatment and study plan

therapeutic management of the prostate Cancer as usual

Procedure

Primary outcomes

EORTC Quality of Life Questionnaire - Core 30 Score (EORTC QLQ-C30 Score)

Time frame: 3 years from diagnosis for cases of prostate cancer and from recruitment for controls

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Nīmes

Other

Registry information

Acronym: EPICAP-QALY

Important dates

Study start: 2015
Primary completion: 2017
Study completion: 2017
First posted: Aug 4, 2016
Registry last updated: Jun 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed